Separation	O
of	O
oxidant-initiated	O
and	O
redox-regulated	O
steps	O
in	O
the	O
NF-kappa	B-protein
B	I-protein
signal	O
transduction	O
pathway	O
.	O

Studies	O
presented	O
here	O
show	O
that	O
overall	O
NF-kappa	B-protein
B	I-protein
signal	O
transduction	O
begins	O
with	O
a	O
parallel	O
series	O
of	O
stimuli-specific	O
pathways	O
through	O
which	O
cytokines	B-protein
(	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
)	O
,	O
oxidants	O
(	O
hydrogen	O
peroxide	O
and	O
mitomycin	O
C	O
)	O
,	O
and	O
phorbol	O
ester	O
(	O
phorbol	O
12-myristate	O
13-acetate	O
)	O
individually	O
initiate	O
signaling	O
.	O

These	O
initial	O
pathways	O
culminate	O
in	O
a	O
common	O
pathway	O
through	O
which	O
all	O
of	O
the	O
stimulating	O
agents	O
ultimately	O
signal	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

We	O
distinguish	O
the	O
stimuli-specific	O
pathways	O
by	O
showing	O
that	O
the	O
oxidative	O
stimuli	O
trigger	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
only	O
one	O
of	O
two	O
human	B-cell_line
T-cell	I-cell_line
lines	I-cell_line
(	O
Wurzburg	B-cell_line
but	O
not	O
Jurkat	B-cell_line
)	O
,	O
whereas	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
and	O
phorbol	O
12-myristate	O
13-acetate	O
readily	O
stimulate	O
in	O
both	O
lines	O
.	O

We	O
propose	O
the	O
common	O
pathway	O
as	O
the	O
simplest	O
way	O
of	O
accounting	O
for	O
the	O
common	O
requirements	O
and	O
properties	O
of	O
the	O
signaling	O
pathway	O
.	O

We	O
include	O
a	O
redox-regulatory	O
mechanism	O
(	O
s	O
)	O
in	O
this	O
common	O
pathway	O
to	O
account	O
for	O
the	O
previously	O
demonstrated	O
redox	O
regulation	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
(	O
in	O
which	O
oxidants	O
do	O
n't	O
activate	O
NF-kappa	B-protein
B	I-protein
)	O
;	O
we	O
put	O
tyrosine	O
phosphorylation	O
in	O
the	O
common	O
pathway	O
by	O
showing	O
that	O
kinase	O
activity	O
(	O
inhibitable	O
by	O
herbimycin	O
A	O
and	O
tyrphostin	O
47	O
)	O
is	O
required	O
for	O
NF-kappa	B-protein
B	I-protein
activation	O
by	O
all	O
stimuli	O
tested	O
in	O
both	O
cell	O
lines	O
.	O

Since	O
internal	O
sites	O
of	O
oxidant	O
production	O
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
the	O
cytokine	B-protein
-stimulated	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
and	O
since	O
tyrosine	O
kinase	O
and	O
phosphatase	O
activities	O
are	O
known	O
to	O
be	O
altered	O
by	O
oxidants	O
,	O
these	O
findings	O
suggest	O
that	O
intracellular	O
redox	O
status	O
controls	O
NF-kappa	B-protein
B	I-protein
activation	O
by	O
regulating	O
tyrosine	O
phosphorylation	O
event	O
(	O
s	O
)	O
within	O
the	O
common	O
step	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
signal	O
transduction	O
pathway	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

91	NULL
,	NULL
pp	NULL
.	NULL

11527-11531	NULL
,	NULL
November	NULL
1994	NULL
Immunology	NULL
Separation	NULL
of	NULL
oxidant-initiated	NULL
and	NULL
redox-regulated	NULL
steps	NULL
in	NULL
the	NULL
NF-xB	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
tyrosine	NULL
phosphorylation	NULL
/inflammatory	NULL
cytokines	NULL
/SRC-kinases	NULL
/glutathione	NULL
)	NULL
MIicHAEL	NULL
T.	NULL
AnNDERSON**	NULL
,	NULL
Frank	NULL
J.	NULL
T	NULL
.	NULL

Staar*t	NULL
?	NULL

,	NULL
Carros	NULL
GiTLERS§	NULL
,	NULL
Leonarp	NULL
A.	NULL
HERZENBERG*	NULL
,	NULL
AND	NULL
LEONORE	NULL
A	NULL
.	NULL

*Department	NULL
of	NULL
Genetics	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305	NULL
;	NULL
and	NULL
$	NULL
Department	NULL
of	NULL
Membrane	NULL
Research	NULL
and	NULL
Biophysics	NULL
,	NULL
Weizmann	NULL
Institute	NULL
of	NULL
Science	NULL
,	NULL
Rehovot	NULL
76100	NULL
Israel	NULL
Contributed	NULL
by	NULL
Leonard	NULL
A.	NULL
Herzenberg	NULL
,	NULL
August	NULL
1	NULL
,	NULL
1994	NULL
ABSTRACT	NULL
Studies	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
overall	NULL
NF-sB	NULL
signal	NULL
transduction	NULL
begins	NULL
with	NULL
a	NULL
parallel	NULL
series	NULL
of	NULL
stimuli-specific	NULL
pathways	NULL
through	NULL
which	NULL
cytokines	NULL
(	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
)	NULL
,	NULL
oxidants	NULL
(	NULL
hydrogen	NULL
peroxide	NULL
and	NULL
mitomycin	NULL
C	NULL
)	NULL
,	NULL
and	NULL
phorbol	NULL
ester	NULL
(	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
)	NULL
individually	NULL
initiate	NULL
signaling	NULL
.	NULL

These	NULL
initial	NULL
pathways	NULL
culminate	NULL
in	NULL
a	NULL
common	NULL
pathway	NULL
through	NULL
which	NULL
all	NULL
of	NULL
the	NULL
stimulating	NULL
agents	NULL
ultimately	NULL
signal	NULL
NF-xB	NULL
activation	NULL
.	NULL

We	NULL
distinguish	NULL
the	NULL
stimuli-specific	NULL
pathways	NULL
by	NULL
showing	NULL
that	NULL
the	NULL
oxidative	NULL
stimuli	NULL
trigger	NULL
NF-xB	NULL
activation	NULL
in	NULL
only	NULL
one	NULL
of	NULL
two	NULL
human	NULL
T-cell	NULL
lines	NULL
(	NULL
Wurzburg	NULL
but	NULL
not	NULL
Jurkat	NULL
)	NULL
,	NULL
whereas	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
readily	NULL
stimulate	NULL
in	NULL
both	NULL
lines	NULL
.	NULL

We	NULL
propose	NULL
the	NULL
common	NULL
pathway	NULL
as	NULL
the	NULL
simplest	NULL
way	NULL
of	NULL
accounting	NULL
for	NULL
the	NULL
common	NULL
requirements	NULL
and	NULL
properties	NULL
of	NULL
the	NULL
signaling	NULL
pathway	NULL
.	NULL

We	NULL
include	NULL
a	NULL
redox-regulatory	NULL
mecha-nism	NULL
(	NULL
s	NULL
)	NULL
in	NULL
this	NULL
common	NULL
pathway	NULL
to	NULL
account	NULL
for	NULL
the	NULL
previously	NULL
demonstrated	NULL
redox	NULL
regulation	NULL
of	NULL
NF-xB	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
in	NULL
which	NULL
oxidants	NULL
do	NULL
n't	NULL
activate	NULL
we	NULL
put	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
the	NULL
common	NULL
pathway	NULL
by	NULL
showing	NULL
that	NULL
kinase	NULL
activity	NULL
(	NULL
inhibitable	NULL
by	NULL
herbimycin	NULL
A	NULL
and	NULL
tyrphostin	NULL
47	NULL
)	NULL
is	NULL
required	NULL
for	NULL
NF-	NULL
»	NULL
cB	NULL
activation	NULL
by	NULL
all	NULL
stimuli	NULL
tested	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

Since	NULL
internal	NULL
sites	NULL
of	NULL
oxidant	NULL
production	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
cytokine-stimulated	NULL
activation	NULL
of	NULL
NF-xB	NULL
,	NULL
and	NULL
since	NULL
tyrosine	NULL
kinase	NULL
and	NULL
phosphatase	NULL
activities	NULL
are	NULL
known	NULL
to	NULL
be	NULL
altered	NULL
by	NULL
oxidants	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
intracellular	NULL
redox	NULL
status	NULL
controls	NULL
NF-xB	NULL
activation	NULL
by	NULL
regulating	NULL
tyrosine	NULL
phosphorylation	NULL
event	NULL
(	NULL
s	NULL
)	NULL
within	NULL
the	NULL
common	NULL
step	NULL
of	NULL
the	NULL
NF-xB	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

The	NULL
activated	NULL
form	NULL
of	NULL
the	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
increases	NULL
transcription	NULL
of	NULL
inflammatory	NULL
response	NULL
genes	NULL
and	NULL
viral	NULL
genes	NULL
,	NULL
notably	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
unactivated	NULL
form	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
sequestered	NULL
in	NULL
the	NULL
cytosol	NULL
by	NULL
member	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
I-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

T-cell	NULL
stimulation	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
agents	NULL
,	NULL
ranging	NULL
from	NULL
phorbol	NULL
esters	NULL
(	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PMA	NULL
)	NULL
and	NULL
cytokines	NULL
[	NULL
tu-mor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
interleukin	NULL
1a	NULL
}	NULL
to	NULL
oxidants	NULL
such	NULL
as	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
H	NULL
;	NULL
0	NULL
;	NULL
)	NULL
and	NULL
UV	NULL
irradiation	NULL
,	NULL
cause	NULL
I-	NULL
«	NULL
B	NULL
to	NULL
dissociate	NULL
from	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

The	NULL
release	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
its	NULL
inhibitory	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
permits	NULL
the	NULL
translocation	NULL
of	NULL
NF-KB	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
DNA	NULL
enhancer	NULL
motifs	NULL
and	NULL
regulates	NULL
transcription	NULL
of	NULL
a	NULL
diverse	NULL
series	NULL
of	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Intracellular	NULL
redox	NULL
levels	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
triggered	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

H	NULL
;	NULL
O	NULL
;	NULL
and	NULL
UV	NULL
triggering	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
often	NULL
used	NULL
as	NULL
models	NULL
of	NULL
this	NULL
common	NULL
redox	NULL
regulation	NULL
;	NULL
however	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
triggering	NULL
by	NULL
these	NULL
oxidants	NULL
is	NULL
genetically	NULL
separable	NULL
from	NULL
the	NULL
common	NULL
,	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

$	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

11527	NULL
redox-sensitive	NULL
mechanism	NULL
that	NULL
operates	NULL
in	NULL
response	NULL
to	NULL
all	NULL
stimuli	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
a	NULL
common	NULL
requirement	NULL
for	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Since	NULL
the	NULL
collective	NULL
activity	NULL
of	NULL
tyrosine	NULL
kinases	NULL
and	NULL
phosphatases	NULL
stimulated	NULL
is	NULL
redox	NULL
regulated	NULL
(	NULL
5-7	NULL
)	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
redox	NULL
regulation	NULL
of	NULL
these	NULL
enzymes	NULL
contributes	NULL
to	NULL
the	NULL
redox	NULL
sensitivity	NULL
of	NULL
the	NULL
common	NULL
step	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

EXPERIMENTAL	NULL
METHODS	NULL
Cell	NULL
Lines	NULL
And	NULL
Culture	NULL
.	NULL

Patrick	NULL
Baeuerle	NULL
(	NULL
Ludwig	NULL
Univer-sitat	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
kindly	NULL
provided	NULL
Wurzburg	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
subclone	NULL
JR	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
TIB152	NULL
)	NULL
.	NULL

Jurkat	NULL
«	NULL
BS5.2	NULL
clone	NULL
,	NULL
derived	NULL
from	NULL
TIB152	NULL
,	NULL
has	NULL
been	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Cell	NULL
Stimulation	NULL
and	NULL
Reporter	NULL
Gene	NULL
Assays	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
inhibitors	NULL
herbimycin	NULL
A	NULL
(	NULL
Biomol	NULL
,	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
tyrphostin	NULL
47	NULL
(	NULL
Biomol	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
H	NULL
;	NULL
0	NULL
;	NULL
(	NULL
Fisher	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
mitomycin	NULL
C	NULL
(	NULL
Mito-C	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
Cetus	NULL
)	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Cells	NULL
to	NULL
be	NULL
UV	NULL
irradiated	NULL
were	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
glucose	NULL
and	NULL
irradiated	NULL
with	NULL
a	NULL
Stratagene	NULL
Stratalinker	NULL
model	NULL
2400	NULL
at	NULL
254	NULL
nm	NULL
.	NULL

After	NULL
irradiation	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

-Galactosidase	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
4-methylumbelliferyl	NULL
$	NULL
5-galactoside	NULL
as	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
except	NULL
that	NULL
buffer	NULL
C	NULL
contained	NULL
10	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
glyc-erol	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
probes	NULL
and	NULL
the	NULL
gel	NULL
retardation	NULL
analysis	NULL
methods	NULL
have	NULL
been	NULL
described	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

RESULTS	NULL
Separation	NULL
of	NULL
Oxidant	NULL
Stimulation	NULL
and	NULL
Redox	NULL
Regulation	NULL
.	NULL

The	NULL
mechanisms	NULL
that	NULL
mediate	NULL
redox	NULL
regulation	NULL
and	NULL
oxidant	NULL
stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
resolved	NULL
by	NULL
studies	NULL
with	NULL
two	NULL
human	NULL
T-cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
and	NULL
Jurkat	NULL
JR.	NULL
We	NULL
obtained	NULL
the	NULL
latter	NULL
line	NULL
from	NULL
P.	NULL
Bacuerle	NULL
and	NULL
provisionally	NULL
call	NULL
it	NULL
Wurzburg	NULL
(	NULL
after	NULL
its	NULL
city	NULL
of	NULL
origin	NULL
)	NULL
.	NULL

Its	NULL
surface	NULL
marker	NULL
expression	NULL
and	NULL
T-cell	NULL
receptor	NULL
rearrangement	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
clearly	NULL
distinguish	NULL
it	NULL
from	NULL
the	NULL
Jurkat	NULL
line	NULL
that	NULL
is	NULL
commonly	NULL
used	NULL
in	NULL
the	NULL
U.S.	NULL
and	NULL
is	NULL
available	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

Surface	NULL
marker	NULL
differences	NULL
(	NULL
data	NULL
not	NULL
Abbreviations	NULL
:	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
TNF-a	NULL
,	NULL
tu-	NULL
mor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
Mito-C	NULL
,	NULL
mitomycin	NULL
C.	NULL
IM.T.A	NULL
.	NULL

and	NULL
F.J.T.S	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

*Present	NULL
address	NULL
:	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
,	NULL
Division	NULL
of	NULL
Immu-nology	NULL
,	NULL
Plesmanlaan	NULL
121	NULL
,	NULL
1066	NULL
CX	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

TTo	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

11528	NULL
-	NULL
Immunology	NULL
:	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

JB1	NULL
JB2	NULL
Bam	NULL
Bgl	NULL
Bam	NULL
Bgl	NULL
wo	NULL
J	NULL
_	NULL
WwW	NULL
OJ	NULL
W	NULL
J	NULL
_	NULL
W	NULL
OJ	NULL
21	NULL
kb	NULL
-f	NULL
»	NULL
6.5	NULL
kb	NULL
-g	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

-	NULL
The	NULL
T-cell	NULL
receptor	NULL
rearrangements	NULL
of	NULL
the	NULL
Wurzburg	NULL
(	NULL
W	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
J	NULL
)	NULL
T-cell	NULL
lines	NULL
are	NULL
distinct	NULL
.	NULL

Genomic	NULL
DNA	NULL
from	NULL
the	NULL
Wurzburg	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
was	NULL
analyzed	NULL
by	NULL
Southern	NULL
analysis	NULL
with	NULL
either	NULL
a	NULL
0.7-kb	NULL
Xba	NULL
JB1	NULL
or	NULL
a	NULL
4.5-kb	NULL
EcoRI	NULL
JB2	NULL
labeled	NULL
genomic	NULL
probe	NULL
after	NULL
restriction	NULL
digestion	NULL
with	NULL
either	NULL
Bai	NULL
II	NULL
or	NULL
BamHI	NULL
.	NULL

shown	NULL
)	NULL
include	NULL
the	NULL
following	NULL
:	NULL
Jurkat	NULL
expresses	NULL
CD2	NULL
,	NULL
CD4SRA	NULL
,	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
CD3	NULL
and	NULL
the	NULL
C305	NULL
idiotype	NULL
(	NULL
12	NULL
)	NULL
;	NULL
Wurzburg	NULL
lacks	NULL
CD2	NULL
and	NULL
CD4SRA	NULL
,	NULL
expresses	NULL
low	NULL
levels	NULL
of	NULL
CD45RO	NULL
and	NULL
CD3	NULL
,	NULL
and	NULL
does	NULL
not	NULL
express	NULL
the	NULL
C305	NULL
idiotype	NULL
.	NULL

Baeuerle	NULL
and	NULL
colleagues	NULL
(	NULL
4	NULL
)	NULL
demonstrated	NULL
that	NULL
NF-KB	NULL
is	NULL
readily	NULL
activated	NULL
in	NULL
the	NULL
Wurzburg	NULL
line	NULL
by	NULL
stimulation	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
UV	NULL
.	NULL

Data	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
confirm	NULL
these	NULL
findings	NULL
and	NULL
show	NULL
further	NULL
that	NULL
another	NULL
oxidative	NULL
stimulus	NULL
,	NULL
Mito-C	NULL
(	NULL
13	NULL
)	NULL
,	NULL
also	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Wurzburg	NULL
.	NULL

These	NULL
oxidative	NULL
stimuli	NULL
,	NULL
however	NULL
,	NULL
do	NULL
not	NULL
detectably	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Jurkat	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
also	NULL
see	NULL
ref	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mechanism	NULL
through	NULL
which	NULL
oxidants	NULL
trigger	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Wurzburg	NULL
does	NULL
not	NULL
function	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
redox-sensitive	NULL
mechanism	NULL
that	NULL
regulates	NULL
NF-KB	NULL
activation	NULL
by	NULL
PMA	NULL
and	NULL
cytokines	NULL
,	NULL
however	NULL
,	NULL
is	NULL
fully	NULL
functional	NULL
in	NULL
Jurkat	NULL
(	NULL
and	NULL
in	NULL
Wurzburg	NULL
)	NULL
.	NULL

Antioxidants	NULL
block	NULL
stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
these	NULL
agents	NULL
in	NULL
Jurkat	NULL
(	NULL
3	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
and	NULL
in	NULL
Wurzburg	NULL
(	NULL
4	NULL
)	NULL
;	NULL
nordihydroguaiaretic	NULL
acid	NULL
completely	NULL
inhibits	NULL
both	NULL
PMA	NULL
and	NULL
TNF-a	NULL
stimulations	NULL
in	NULL
Jurkat	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
and	NULL
N-acetylcysteine	NULL
,	NULL
which	NULL
acts	NULL
both	NULL
as	NULL
an	NULL
antiox-idant	NULL
and	NULL
as	NULL
a	NULL
source	NULL
of	NULL
cysteine	NULL
for	NULL
replenishing	NULL
intracellular	NULL
glutathione	NULL
,	NULL
blocks	NULL
NF-KB	NULL
activation	NULL
consistently	NULL
but	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
(	NULL
40	NULL
%	NULL
for	NULL
TNF-a	NULL
@	NULL
stimulation	NULL
;	NULL
75	NULL
%	NULL
for	NULL
PMA	NULL
stimulation	NULL
)	NULL
in	NULL
both	NULL
Jurkat	NULL
and	NULL
Wurzburg	NULL
.	NULL

Wurzburg	NULL
Jurkat	NULL
H20z	NULL
H	NULL
;	NULL
02	NULL
Wurzburg	NULL
_	NULL
Jurkat	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
Taken	NULL
together	NULL
,	NULL
the	NULL
above	NULL
findings	NULL
demonstrate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
redox	NULL
regulated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
despite	NULL
the	NULL
inability	NULL
of	NULL
oxidants	NULL
to	NULL
stimulate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
redox-sensitive	NULL
mechanisms	NULL
must	NULL
be	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
.	NULL

One	NULL
,	NULL
present	NULL
only	NULL
in	NULL
Wurzburg	NULL
,	NULL
allows	NULL
oxidants	NULL
such	NULL
as	NULL
H	NULL
;	NULL
O	NULL
;	NULL
to	NULL
trigger	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
other	NULL
,	NULL
present	NULL
both	NULL
in	NULL
Jurkat	NULL
and	NULL
Wurzburg	NULL
,	NULL
allows	NULL
intracellular	NULL
redox	NULL
levels	NULL
to	NULL
regulate	NULL
the	NULL
extent	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Protein	NULL
Tyrosine	NULL
Phosphorylation	NULL
Is	NULL
a	NULL
General	NULL
Requirement	NULL
for	NULL
NF-xB	NULL
Activation	NULL
.	NULL

Karin	NULL
and	NULL
colleagues	NULL
(	NULL
5	NULL
)	NULL
,	NULL
working	NULL
with	NULL
the	NULL
HeLa	NULL
cell	NULL
line	NULL
,	NULL
have	NULL
shown	NULL
that	NULL
UV	NULL
stimulation	NULL
activates	NULL
Src	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
,	NULL
which	NULL
phosphorylate	NULL
particular	NULL
protein	NULL
tyrosine	NULL
residues	NULL
.	NULL

This	NULL
activation	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
another	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
studies	NULL
that	NULL
follow	NULL
confirm	NULL
the	NULL
requirement	NULL
for	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
the	NULL
oxidant	NULL
stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
and	NULL
implicate	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
as	NULL
essential	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
both	NULL
by	NULL
oxidative	NULL
and	NULL
nonoxidative	NULL
stimuli	NULL
.	NULL

Thus	NULL
we	NULL
demonstrate	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
a	NULL
general	NULL
requirement	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Reporter	NULL
Gene	NULL
Studies	NULL
.	NULL

Cytokines	NULL
and	NULL
PMA	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
stable	NULL
,	NULL
integrated	NULL
reporter	NULL
gene	NULL
construct	NULL
(	NULL
tri-	NULL
«	NULL
B	NULL
lacZ	NULL
in	NULL
Jurkat	NULL
)	NULL
whose	NULL
transcription	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
tandem	NULL
trimer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Two	NULL
differently	NULL
acting	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
,	NULL
herbimycin	NULL
A	NULL
and	NULL
tyrphostin	NULL
47	NULL
,	NULL
completely	NULL
inhibit	NULL
stimulation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
by	NULL
either	NULL
PMA	NULL
or	NULL
TNF-a	NULL
(	NULL
Figs	NULL
.	NULL

3B	NULL
and	NULL
4	NULL
)	NULL
.	NULL

This	NULL
complete	NULL
inhibition	NULL
is	NULL
observed	NULL
after	NULL
either	NULL
a	NULL
short-term	NULL
,	NULL
high-dose	NULL
herbimycin	NULL
A	NULL
(	NULL
4	NULL
hr	NULL
,	NULL
10	NULL
ug/ml	NULL
)	NULL
preincubation	NULL
or	NULL
the	NULL
long-term	NULL
,	NULL
low-dose	NULL
preincubation	NULL
conditions	NULL
(	NULL
18	NULL
hr	NULL
,	NULL
0.5-3	NULL
pg/ml	NULL
)	NULL
used	NULL
by	NULL
many	NULL
laboratories	NULL
.	NULL

Herbimycin	NULL
A	NULL
is	NULL
a	NULL
widely	NULL
used	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
that	NULL
is	NULL
attributed	NULL
to	NULL
be	NULL
a	NULL
selective	NULL
inhibitor	NULL
of	NULL
Src-like	NULL
kinases	NULL
(	NULL
15	NULL
)	NULL
by	NULL
targeting	NULL
their	NULL
degradation	NULL
.	NULL

It	NULL
is	NULL
relatively	NULL
nontoxic	NULL
and	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
protein	NULL
synthesis	NULL
,	NULL
PMA/	NULL
ionomycin	NULL
stimulation	NULL
of	NULL
interleukin	NULL
2	NULL
production	NULL
,	NULL
or	NULL
signaling	NULL
via	NULL
pathways	NULL
that	NULL
do	NULL
not	NULL
depend	NULL
on	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
[	NULL
e.g	NULL
.	NULL

,	NULL
pathways	NULL
dependent	NULL
upon	NULL
serine/threonine	NULL
kinases	NULL
or	NULL
guanine	NULL
nucleotide-binding-protein-dependent	NULL
signaling	NULL
pathways	NULL
(	NULL
16-18	NULL
)	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
only	NULL
minimally	NULL
decreases	NULL
the	NULL
PMA-signaled	NULL
induction	NULL
of	NULL
the	NULL
T-cell	NULL
surface	NULL
``	NULL
activation	NULL
``	NULL
antigen	NULL
,	NULL
CD69	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
ref	NULL
.	NULL

19	NULL
)	NULL
,	NULL
although	NULL
,	NULL
Wurzburg	NULL
Jurkat	NULL
Mito-C	NULL
Mito-C	NULL
UV	NULL
UV	NULL
Un	NULL
T	NULL
100	NULL
Un	NULL
T	NULL
100	NULL
150	NULL
75	NULL
150	NULL
300	NULL
75	NULL
150	NULL
300	NULL
5	NULL
10	NULL
20	NULL
5	NULL
10	NULL
20	NULL
``	NULL
+	NULL
>	NULL
Wh	NULL
-	NULL
#	NULL
was	NULL
wite	NULL
bat	NULL
-	NULL
bug	NULL
tn	NULL
tual	NULL
bs	NULL
*+	NULL
t	NULL
b=	NULL
»	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Jurkat	NULL
and	NULL
Wurzburg	NULL
lines	NULL
differ	NULL
in	NULL
their	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
response	NULL
to	NULL
oxidative	NULL
stimuli	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
4	NULL
hr	NULL
after	NULL
stimulation	NULL
of	NULL
Wurzburg	NULL
or	NULL
Jurkat	NULL
cells	NULL
.	NULL

Un	NULL
,	NULL
unstimulated	NULL
;	NULL
T	NULL
,	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
;	NULL
H20	NULL
;	NULL
,	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
100	NULL
and	NULL
150	NULL
uM	NULL
)	NULL
,	NULL
UV	NULL
,	NULL
UV-C	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
20	NULL
joules	NULL
)	NULL
;	NULL
Mito-C	NULL
,	NULL
Mito-C	NULL
(	NULL
75	NULL
,	NULL
150	NULL
,	NULL
and	NULL
300	NULL
ug/ml	NULL
)	NULL
,	NULL
a	NULL
third	NULL
oxidative	NULL
stimulus	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
.	NULL

Immunology	NULL
:	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

A	NULL
«	NULL
100	NULL
{	NULL
w	NULL
PMA	NULL
g	NULL
807	NULL
£	NULL
#	NULL
CD69	NULL
T	NULL
)	NULL
4	NULL
°	NULL
604	NULL
©	NULL
2	NULL
T	NULL
40	NULL
-	NULL
PMA	NULL
Aa	NULL
20	NULL
-	NULL
[	NULL
IL-ZR	NULL
|	NULL
100	NULL
rs	NULL
80+	NULL
“	NULL
5	NULL
60	NULL
&	NULL
494	NULL
MA	NULL
201	NULL
TNFZ	NULL
-or	NULL
r	NULL
r	NULL
r	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
1.0	NULL
Herbimycin	NULL
A	NULL
,	NULL
ug/ml	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Herbimycin	NULL
A	NULL
specifically	NULL
blocks	NULL
NF-	NULL
«	NULL
B-dependent	NULL
tran-scription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Surface	NULL
expression	NULL
of	NULL
PMA-induced	NULL
activation	NULL
mark-ers	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
concentrations	NULL
of	NULL
herbimycin	NULL
A	NULL
for	NULL
18	NULL
hr	NULL
,	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
16	NULL
hr	NULL
in	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
herbimycin	NULL
A	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
and	NULL
CD69	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
analyses	NULL
after	NULL
staining	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
phycoerythrin-labeled	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Frequency	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
indicated	NULL
surface	NULL
marker	NULL
is	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
fluorochrome-conjugated	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
gating	NULL
to	NULL
include	NULL
cells	NULL
with	NULL
associated	NULL
fluorescence	NULL
greater	NULL
than	NULL
two	NULL
standard	NULL
deviations	NULL
above	NULL
the	NULL
median	NULL
autofluorescence	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Reporter	NULL
gene	NULL
assay	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Jurkat	NULL
«	NULL
B5.2	NULL
cells	NULL
with	NULL
an	NULL
integrated	NULL
construct	NULL
consisting	NULL
of	NULL
three	NULL
«	NULL
B	NULL
sites	NULL
linked	NULL
to	NULL
lacZ	NULL
were	NULL
preincubated	NULL
for	NULL
18	NULL
hr	NULL
with	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
of	NULL
herbimycin	NULL
A	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
-galactosidase	NULL
activity	NULL
was	NULL
assayed	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
lacZ	NULL
activity	NULL
obtained	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
inhibitor	NULL
(	NULL
an	NULL
index	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
)	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
the	NULL
standard	NULL
deviation	NULL
of	NULL
10	NULL
replicates	NULL
per	NULL
condition	NULL
.	NULL

as	NULL
Fig	NULL
.	NULL

3B	NULL
shows	NULL
,	NULL
it	NULL
completely	NULL
inhibits	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
induction	NULL
of	NULL
interleukin	NULL
2	NULL
receptor	NULL
surface	NULL
expression	NULL
by	NULL
PMA	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-controlled	NULL
reporter	NULL
gene	NULL
in	NULL
Jurkat	NULL
is	NULL
also	NULL
inhibited	NULL
by	NULL
a	NULL
pseudosubstrate	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
tyrphostin	NULL
47	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Preincubation	NULL
for	NULL
30	NULL
min	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
tyrphostin	NULL
47	NULL
concentrations	NULL
blocks	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
tri-	NULL
«	NULL
B	NULL
lacZ	NULL
reporter	NULL
gene	NULL
in	NULL
cells	NULL
stimulated	NULL
either	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
with	NULL
different	NULL
modes	NULL
of	NULL
action	NULL
block	NULL
signaling	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
.	NULL

Gel	NULL
Retardation	NULL
Studies	NULL
.	NULL

The	NULL
herbimycin	NULL
A	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B-directed	NULL
gene	NULL
expression	NULL
is	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
to	NULL
acti-	NULL
jePMA	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
%	NULL
100	NULL
80	NULL
60	NULL
40	NULL
TNEI	NULL
20	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
Tyrphostin	NULL
47	NULL
,	NULL
uM	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Tyrphostin	NULL
47	NULL
specifically	NULL
blocks	NULL
NF-	NULL
«	NULL
B-dependent	NULL
tran-scription	NULL
.	NULL

Jurkat	NULL
«	NULL
B5.2	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
tyrphostin	NULL
47	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
A-galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
-	NULL
11529	NULL
NF-B	NULL
AP	NULL
None	NULL
PMA	NULL
[	NULL
NF	NULL
None	NULL
PMA	NULL
T	NULL
Herbimycin	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Herbimycin	NULL
A	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
AP-1	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
for	NULL
4	NULL
hr	NULL
and	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
or	NULL
PMA	NULL
.	NULL

Gel	NULL
retardation	NULL
data	NULL
are	NULL
shown	NULL
for	NULL
the	NULL
same	NULL
extracts	NULL
analyzed	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
Left	NULL
)	NULL
and	NULL
an	NULL
AP-1	NULL
probe	NULL
(	NULL
Right	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
inducible	NULL
band	NULL
.	NULL

vate/translocate	NULL
free	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
bands	NULL
are	NULL
readily	NULL
detectable	NULL
in	NULL
gels	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
PMA	NULL
or	NULL
TNF-a-stimulated	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
these	NULL
bands	NULL
are	NULL
missing	NULL
in	NULL
gels	NULL
of	NULL
extracts	NULL
from	NULL
cells	NULL
preincubated	NULL
with	NULL
herbimycin	NULL
A	NULL
(	NULL
4	NULL
hr	NULL
,	NULL
10	NULL
ug/ml	NULL
)	NULL
prior	NULL
to	NULL
stimulation	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Bomsztyk	NULL
and	NULL
colleagues	NULL
(	NULL
23	NULL
)	NULL
,	NULL
using	NULL
another	NULL
herbimycin	NULL
A	NULL
treatment	NULL
protocol	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IL-1-a	NULL
,	NULL
recently	NULL
reported	NULL
that	NULL
herbimycin	NULL
A	NULL
does	NULL
not	NULL
inhibit	NULL
PMA	NULL
activation	NULL
of	NULL
A	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
also	NULL
failed	NULL
to	NULL
inhibit	NULL
PMA-stimulated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
herbimycin	NULL
A	NULL
when	NULL
we	NULL
used	NULL
this	NULL
protocol	NULL
(	NULL
10	NULL
ug/ml	NULL
for	NULL
1	NULL
hr	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
since	NULL
herbimycin	NULL
A	NULL
fully	NULL
inhibits	NULL
PMA-stimulated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
when	NULL
cells	NULL
are	NULL
pretreated	NULL
for	NULL
a	NULL
longer	NULL
time	NULL
(	NULL
10	NULL
ug/ml	NULL
for	NULL
4	NULL
hr	NULL
;	NULL
see	NULL
above	NULL
)	NULL
,	NULL
we	NULL
ascribe	NULL
the	NULL
lack	NULL
of	NULL
inhibition	NULL
with	NULL
the	NULL
Bomstyk	NULL
protocol	NULL
to	NULL
its	NULL
inability	NULL
to	NULL
deplete	NULL
intracellular	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
to	NULL
a	NULL
level	NULL
that	NULL
would	NULL
limit	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
a	NULL
strong	NULL
stimulus	NULL
such	NULL
as	NULL
PMA	NULL
.	NULL

Completing	NULL
the	NULL
demonstration	NULL
of	NULL
the	NULL
generality	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
requirements	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
the	NULL
studies	NULL
conducted	NULL
with	NULL
the	NULL
Wurzburg	NULL
cells	NULL
showing	NULL
NF-	NULL
<	NULL
B	NULL
e	NULL
None	NULL
-	NULL
PMA	NULL
TNF	NULL
-	NULL
H0-	NULL
Mito-	NULL
(	NULL
Herbimycin	NULL
2°4	NULL
r	NULL
Cibola	NULL
>	NULL
bas	NULL
la	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Herbimycin	NULL
A	NULL
blocks	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
oxidants	NULL
.	NULL

The	NULL
oxidant-sensitive	NULL
Wurzburg	NULL
cell	NULL
line	NULL
was	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
TNF-a	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
,	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
150	NULL
uM	NULL
)	NULL
,	NULL
or	NULL
Mito-C	NULL
(	NULL
300	NULL
uM	NULL
)	NULL
after	NULL
a	NULL
4-hr	NULL
preincubation	NULL
with	NULL
or	NULL
without	NULL
herbimycin	NULL
A	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
.	NULL

11530	NULL
-	NULL
Immunology	NULL
:	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

that	NULL
herbimycin	NULL
A	NULL
blocks	NULL
the	NULL
H	NULL
;	NULL
O	NULL
;	NULL
and	NULL
Mito-C	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
confirm	NULL
previous	NULL
findings	NULL
demonstrating	NULL
that	NULL
herbimycin	NULL
A	NULL
blocks	NULL
both	NULL
H	NULL
;	NULL
O	NULL
»	NULL
and	NULL
yirradiation	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
and	NULL
that	NULL
tyrphostin	NULL
47	NULL
blocks	NULL
UV-stimulated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
is	NULL
required	NULL
both	NULL
for	NULL
the	NULL
oxidant-initiated	NULL
and	NULL
redox-regulated	NULL
components	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

PMA	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
activation	NULL
of	NULL
AP-1	NULL
,	NULL
another	NULL
transcription	NULL
factor	NULL
important	NULL
for	NULL
T-cell	NULL
function	NULL
.	NULL

This	NULL
stimulation	NULL
is	NULL
not	NULL
redox-regulated	NULL
and	NULL
does	NULL
not	NULL
involve	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
we	NULL
show	NULL
above	NULL
,	NULL
it	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
herbimycin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
demonstration	NULL
that	NULL
herbimycin	NULL
A	NULL
inhibits	NULL
the	NULL
stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
therefore	NULL
reflects	NULL
the	NULL
selective	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

DISCUSSION	NULL
Studies	NULL
presented	NULL
here	NULL
use	NULL
two	NULL
human	NULL
T-cell	NULL
lines	NULL
,	NULL
Wurzburg	NULL
and	NULL
Jurkat	NULL
,	NULL
to	NULL
distinguish	NULL
the	NULL
mechanism	NULL
through	NULL
which	NULL
oxidants	NULL
specifically	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
from	NULL
the	NULL
downstream	NULL
mechanism	NULL
in	NULL
which	NULL
oxidants	NULL
serve	NULL
as	NULL
essential	NULL
messengers	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
initiated	NULL
by	NULL
all	NULL
NF-KB	NULL
inducers	NULL
.	NULL

As	NULL
we	NULL
have	NULL
shown	NULL
,	NULL
oxidants	NULL
readily	NULL
induce	NULL
NF-KB	NULL
activation	NULL
in	NULL
Wurzburg	NULL
but	NULL
do	NULL
not	NULL
trigger	NULL
the	NULL
induction	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
Jurkat	NULL
;	NULL
however	NULL
,	NULL
nonoxidative	NULL
molecules	NULL
such	NULL
as	NULL
PMA	NULL
and	NULL
TNF	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
both	NULL
Wurzburg	NULL
and	NULL
Jurkat	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
oxidants	NULL
trigger	NULL
insufficient	NULL
signals	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Jurkat	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
this	NULL
factor	NULL
in	NULL
both	NULL
T-cell	NULL
lines	NULL
by	NULL
other	NULL
stimuli	NULL
depends	NULL
upon	NULL
the	NULL
generation	NULL
of	NULL
intracellular	NULL
oxidants	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
oxidants	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
other	NULL
agents	NULL
initiate	NULL
signal	NULL
transduction	NULL
by	NULL
triggering	NULL
separate	NULL
,	NULL
inducer-specific	NULL
``	NULL
receptors	NULL
``	NULL
and	NULL
that	NULL
the	NULL
signals	NULL
generated	NULL
by	NULL
these	NULL
inducer-specific	NULL
receptors	NULL
ultimately	NULL
flow	NULL
through	NULL
a	NULL
common	NULL
,	NULL
redox-regulated	NULL
step	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL
'	NULL

Recent	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
cytokine-stimulated	NULL
production	NULL
of	NULL
mitochondria-derived	NULL
oxidants	NULL
regulate	NULL
,	NULL
but	NULL
do	NULL
not	NULL
initiate	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
essence	NULL
,	NULL
these	NULL
studies	NULL
show	NULL
that	NULL
cytokine-stimulated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
requires	NULL
superoxide	NULL
production	NULL
by	NULL
mitochondria	NULL
but	NULL
that	NULL
this	NULL
activation	NULL
does	NULL
not	NULL
occur	NULL
without	NULL
additional	NULL
signaling	NULL
events	NULL
.	NULL

Since	NULL
the	NULL
stimulation	NULL
of	NULL
mitochondrial	NULL
oxidant	NULL
production	NULL
must	NULL
occur	NULL
late	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
and	NULL
is	NULL
neces-sary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
it	NULL
occurs	NULL
in	NULL
the	NULL
common	NULL
step	NULL
of	NULL
the	NULL
pathway	NULL
and	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
redox	NULL
regulatory	NULL
activity	NULL
of	NULL
this	NULL
step	NULL
(	NULL
s	NULL
)	NULL
,	NULL
perhaps	NULL
,	NULL
as	NULL
discussed	NULL
below	NULL
,	NULL
by	NULL
regulating	NULL
essential	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Tyrosine	NULL
kinase	NULL
activity	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
to	NULL
certain	NULL
of	NULL
the	NULL
inducer-specific	NULL
steps	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
pathway	NULL
,	NULL
notably	NULL
in	NULL
the	NULL
early	NULL
signaling	NULL
events	NULL
triggered	NULL
by	NULL
anti-CD3	NULL
and	NULL
by	NULL
oxidants	NULL
(	NULL
24	NULL
,	NULL
26	NULL
,	NULL
29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
,	NULL
tyrosine	NULL
kinase	NULL
inhibitors	NULL
(	NULL
herbimy-cin	NULL
A	NULL
and	NULL
tyrphostin	NULL
47	NULL
)	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
all	NULL
stimuli	NULL
tested	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
oxidants	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
PMA	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
is	NULL
a	NULL
common	NULL
requirement	NULL
for	NULL
the	NULL
triggering	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
hence	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
kinases	NULL
is	NULL
essential	NULL
to	NULL
the	NULL
passage	NULL
of	NULL
signals	NULL
through	NULL
the	NULL
common	NULL
pathway	NULL
step	NULL
.	NULL

Thus	NULL
our	NULL
data	NULL
implicate	NULL
both	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
(	NULL
protein	NULL
tyrosine	NULL
phos-phorylation	NULL
)	NULL
and	NULL
redox	NULL
regulation	NULL
in	NULL
this	NULL
common	NULL
step	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
attractive	NULL
because	NULL
it	NULL
provides	NULL
a	NULL
plausible	NULL
mechanism	NULL
through	NULL
which	NULL
the	NULL
redox	NULL
environment	NULL
can	NULL
regulate	NULL
signal	NULL
flow	NULL
through	NULL
the	NULL
pathway	NULL
.	NULL

Tyrosine	NULL
kinase	NULL
activity	NULL
can	NULL
be	NULL
increased	NULL
by	NULL
oxidants	NULL
and	NULL
decreased	NULL
by	NULL
antioxidants	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
tyrosine	NULL
phosphatase	NULL
activity	NULL
,	NULL
which	NULL
dephos-phorylates	NULL
the	NULL
protein	NULL
tyrosine	NULL
residues	NULL
that	NULL
are	NULL
phosphor	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Proposed	NULL
location	NULL
of	NULL
redox-regulatory	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
in	NULL
the	NULL
stimuli	NULL
(	NULL
inducer	NULL
)	NULL
-specific	NULL
and	NULL
common	NULL
portions	NULL
of	NULL
the	NULL
overall	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

GSH	NULL
,	NULL
glutathione	NULL
.	NULL

ylated	NULL
by	NULL
tyrosine	NULL
kinases	NULL
,	NULL
is	NULL
inhibited	NULL
by	NULL
oxidants	NULL
and	NULL
protected	NULL
by	NULL
antioxidants	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
redox-regulating	NULL
agents	NULL
such	NULL
as	NULL
N-acetylcysteine	NULL
and	NULL
nordihydroguaiaretic	NULL
acid	NULL
,	NULL
which	NULL
increase	NULL
the	NULL
cell	NULL
's	NULL
ability	NULL
to	NULL
reduce/	NULL
inactivate	NULL
internally	NULL
generated	NULL
oxidants	NULL
,	NULL
controls	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
controlling	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
mitochondrial-derived	NULL
oxidants	NULL
increase	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
TNF-a	NULL
becomes	NULL
an	NULL
effective	NULL
stimulator	NULL
of	NULL
overall	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
when	NULL
cells	NULL
are	NULL
pretreated	NULL
with	NULL
the	NULL
agent	NULL
buthionine	NULL
sulfoximine	NULL
,	NULL
which	NULL
depletes	NULL
glutathione	NULL
,	NULL
the	NULL
principal	NULL
intracellular	NULL
redox	NULL
buffer	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
is	NULL
barely	NULL
detectable	NULL
in	NULL
phos-photyrosine	NULL
blots	NULL
when	NULL
cells	NULL
are	NULL
stimulated	NULL
at	NULL
normal	NULL
glu-tathione	NULL
levels	NULL
;	NULL
however	NULL
,	NULL
blots	NULL
of	NULL
extracts	NULL
from	NULL
glutathione-depleted	NULL
cells	NULL
demonstrate	NULL
that	NULL
TNF-a	NULL
stimulates	NULL
as	NULL
much	NULL
overall	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
anti-CD3	NULL
.	NULL

This	NULL
redox	NULL
regulation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
would	NULL
be	NULL
readily	NULL
explained	NULL
if	NULL
,	NULL
as	NULL
we	NULL
propose	NULL
,	NULL
the	NULL
signals	NULL
generated	NULL
by	NULL
triggering	NULL
cells	NULL
with	NULL
oxidants	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
phorbol	NULL
esters	NULL
converge	NULL
on	NULL
a	NULL
common	NULL
pathway	NULL
that	NULL
leads	NULL
initially	NULL
to	NULL
generation	NULL
of	NULL
mitochondrial	NULL
oxidants	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
increases	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
the	NULL
transmission	NULL
of	NULL
signals	NULL
that	NULL
stimulate	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Patrick	NULL
Bacuerle	NULL
for	NULL
the	NULL
Wurzburg	NULL
cell	NULL
line	NULL
;	NULL
Dr.	NULL
Michael	NULL
Cleary	NULL
kindly	NULL
provided	NULL
the	NULL
J	NULL
;	NULL
and	NULL
J	NULL
&	NULL
;	NULL
probes	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Drs	NULL
.	NULL

Stephen	NULL
W.	NULL
Ela	NULL
and	NULL
Mario	NULL
Roederer	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
for	NULL
critical	NULL
comment	NULL
on	NULL
this	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Gary	NULL
P.	NULL
Nolan	NULL
for	NULL
constructive	NULL
advice	NULL
and	NULL
help	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
ideas	NULL
presented	NULL
here	NULL
and	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
itself	NULL
.	NULL

M.T.A	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
(	NULL
FI0STO19	NULL
)	NULL
from	NULL
the	NULL
University-wide	NULL
AIDS	NULL
Research	NULL
Program	NULL
.	NULL

F.J.T.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
Department	NULL
of	NULL
Genetics	NULL
funds	NULL
.	NULL

This	NULL
work	NULL
is	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Library	NULL
of	NULL
Medicine	NULL
Grant	NULL
LMO4836	NULL
and	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA42509	NULL
and	NULL
ROI	NULL
1	NULL
.	NULL

Bacuerie	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
.	NULL

2	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
211-220	NULL
.	NULL

3	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9943-9947	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

Immunology	NULL
:	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
.	NULL

Devary	NULL
,	NULL
Y.	NULL
,	NULL
Gottlieb	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
1081-1091	NULL
.	NULL

Bauskin	NULL
,	NULL
A.	NULL
,	NULL
Alkalay	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
685-696	NULL
.	NULL

Fischer	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Charbonneau	NULL
,	NULL
H.	NULL
&	NULL
Tonks	NULL
,	NULL
N.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
253	NULL
,	NULL
401-406	NULL
.	NULL

Mattilla	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Fiering	NULL
,	NULL
S.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Mccutcheon	NULL
,	NULL
M.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
&	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4425-4433	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Mueller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2917-2923	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Raju	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Anderson	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Ela	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9	NULL
,	NULL
299-306	NULL
.	NULL

Weiss	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
1284-1299	NULL
.	NULL

Sinha	NULL
,	NULL
B.	NULL
K.	NULL
&	NULL
Mimnaugh	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

8	NULL
,	NULL
567-581	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
Gougerot-Pocidalo	NULL
,	NULL
M.	NULL
,	NULL
Aillet	NULL
,	NULL
F.	NULL
&	NULL
Virelizier	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
3386-3393	NULL
.	NULL

Uehara	NULL
,	NULL
Y.	NULL
,	NULL
Murakami	NULL
,	NULL
Y.	NULL
,	NULL
Sugimoto	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Mizuno	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

49	NULL
,	NULL
780-785	NULL
.	NULL

Graber	NULL
,	NULL
M.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
&	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

4	NULL
,	NULL
1201-1210	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Fletcher	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Siegel	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Phillips	NULL
,	NULL
A.	NULL
F.	NULL
&	NULL
Sameison	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
7722-1726	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
(	NULL
1994	NULL
)	NULL
-	NULL
11531	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Linsley	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Mechanisms	NULL
of	NULL
Lymphocyte	NULL
Activation	NULL
and	NULL
Immune	NULL
Regulation	NULL
IV	NULL
,	NULL
eds	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
&	NULL
Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
Plenum	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

23-27	NULL
.	NULL

Vandenberghe	NULL
,	NULL
P.	NULL
,	NULL
Verwiighen	NULL
,	NULL
J.	NULL
,	NULL
Vaeck	NULL
,	NULL
F.	NULL
V.	NULL
&	NULL
Ceuppens	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Immunology	NULL
78	NULL
,	NULL
210-217	NULL
.	NULL

Fukazawa	NULL
,	NULL
H.	NULL
,	NULL
Mizuno	NULL
,	NULL
S.	NULL
&	NULL
Uehara	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biockem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

173	NULL
,	NULL
276-282	NULL
.	NULL

Levitzki	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3275-3282	NULL
.	NULL

Uehara	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Fukazawa	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
370-379	NULL
.	NULL

Iwasaki	NULL
,	NULL
T.	NULL
,	NULL
Uehara	NULL
,	NULL
Y.	NULL
,	NULL
Graves	NULL
,	NULL
L.	NULL
,	NULL
Rachie	NULL
,	NULL
N.	NULL
&	NULL
Bomsztyk	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

298	NULL
,	NULL
240-244	NULL
.	NULL

Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Kirhara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Myers	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1212-1220	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Tuel-Ahigren	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Dibirdik	NULL
,	NULL
I.	NULL
,	NULL
Meyers	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Song	NULL
,	NULL
C.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
252-256	NULL
.	NULL

Devary	NULL
,	NULL
Y.	NULL
,	NULL
Rosotto	NULL
,	NULL
C.	NULL
,	NULL
DiDonnato	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1442-1445	NULL
.	NULL

Mannervik	NULL
,	NULL
B.	NULL
,	NULL
Carlberg	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Larsen	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
in	NULL
Glutathione	NULL
:	NULL
Chemical	NULL
,	NULL
Biochemical	NULL
,	NULL
and	NULL
Medical	NULL
Aspects	NULL
,	NULL
Coenzymes	NULL
and	NULL
Cofactors	NULL
,	NULL
eds	NULL
.	NULL

Dolphin	NULL
,	NULL
D.	NULL
,	NULL
Avramovic	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Poulson	NULL
,	NULL
R.	NULL
(	NULL
Academic	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
Vol	NULL
.	NULL

3A	NULL
,	NULL
pp	NULL
.	NULL

475-516	NULL
.	NULL

Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Beyaert	NULL
,	NULL
R.	NULL
,	NULL
Vandevoorde	NULL
,	NULL
V.	NULL
,	NULL
Haege-man	NULL
,	NULL
G.	NULL
&	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3095-3104	NULL
.	NULL

Mustelin	NULL
,	NULL
T.	NULL
,	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Isakov	NULL
,	NULL
N.	NULL
&	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1584-1587	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
Anderson	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Staal	NULL
,	NULL
G.	NULL
E.	NULL
J.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Gitler	NULL
,	NULL
C.	NULL
&	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
3619-3622	NULL
.	NULL

